NCT07338955

Brief Summary

This study aims to translate, culturally adapt, and validate the Urdu version of the Disabilities of the Arm, Shoulder, and Hand (DASH) questionnaire for individuals with upper limb disabilities. Since no validated Urdu version currently exists, Urdu-speaking patients face communication barriers that may lead to inaccurate assessment and limited clinical decision-making. By ensuring semantic equivalence through forward-backward translation and expert review, the study seeks to develop a version that is both linguistically accurate and culturally appropriate.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
385

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Nov 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 3, 2025

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

December 4, 2025

Completed
6 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 10, 2025

Completed
1 month until next milestone

First Posted

Study publicly available on registry

January 14, 2026

Completed
6 days until next milestone

Study Completion

Last participant's last visit for all outcomes

January 20, 2026

Completed
Last Updated

January 14, 2026

Status Verified

January 1, 2026

Enrollment Period

1 month

First QC Date

December 4, 2025

Last Update Submit

January 7, 2026

Conditions

Keywords

Validation and Reliability of DASH Questionnaire

Outcome Measures

Primary Outcomes (1)

  • reliability and validity

    To assess the reliability and validity of the Urdu version of the DASH Questionnaire.

    December 2025 to January 2026

Secondary Outcomes (1)

  • cultural adaptation

    October 2025 to November2025

Study Arms (1)

Group 1

Data will be collected from experienced physiotherpist

Other: All participants (Aviane)Other: data collection

Interventions

Data will be collected from patients having upper limb pain or disability

Group 1

Data will be collected from patients having upper limb pain or disbility

Group 1

Eligibility Criteria

Age18 Years - 45 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Patients with upper limb disability or pain for more than 4 weeks

You may qualify if:

  • Diagnosed with any upper limb disability or deformity . Able to read, understand and speak Urdu. Individuals with symptoms enduring for at least one week .

You may not qualify if:

  • Cognitive impairment or psychiatric illness that hinders understanding of the questionnaire.
  • Patients with congenital deformities. Refusal to give informed consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University

Karachi, Sindh, 75300, Pakistan

RECRUITING

Related Publications (2)

  • Basakci Calik B, Demir P, Gur Kabul E, Caglayan BC, Keskin A, Karasu U. Validity and Reliability of the Turkish Version of the DASH-TR Questionnaire in Rheumatoid Arthritis Patients, Based on Rasch Analysis. Int J Rheum Dis. 2022 Aug;25(8):851-860. doi: 10.1111/1756-185X.14358. Epub 2022 Jun 6.

  • Puentes Gutierrez AB, Garcia Bascones M, Jimenez Diaz F, Cuena Boy R, Puentes Gutierrez R. [Validity and reliability of DASH questionnaire in women who suffer from lymphedema as a side effect of a breast cancer treatment]. Rehabilitacion (Madr). 2023 Jul-Sep;57(3):100780. doi: 10.1016/j.rh.2022.100780. Epub 2023 Feb 3. Spanish.

MeSH Terms

Interventions

ethinyl estradiol, levonorgestrel drug combinationData Collection

Intervention Hierarchy (Ancestors)

Epidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Central Study Contacts

Rabia Khan, Masters in Physiotherapy

CONTACT

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Target Duration
385 Weeks
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

December 4, 2025

First Posted

January 14, 2026

Study Start

November 3, 2025

Primary Completion

December 10, 2025

Study Completion

January 20, 2026

Last Updated

January 14, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will not share

Locations